🚨 Durva + chemo demonstrated statistically significant and clinically meaningful improvement in event-free survival and overall survival for muscle-invasive bladder cancer in NIAGARA Phase III trial astrazeneca.com/media-centre/p…

Starting the afternoon session GUARD Consortium symposium discussing about #bladder cancer moderated by two key opinion leaders Joan Palou Redorta and Félix Guerrero-Ramos

🎉Fantastic #GUARDSymposium2024 GUARD Consortium in Madrid! 📖Excellent scientific program including collaborative projects! 🔝International speakers 🍽️Dinner with great new friends Ashish M. Kamat, MD, MBBS GUO-AEU IBCG Joan Palou Redorta Enrique Grande Álvaro Pinto Javier Puente Daniel Castellano

🥇Premio Actas Urológicas al artículo más citado en 2023🥇 "Current treatments for BCG failure in non-muscle invasive bladder cancer (NMIBC)", del que es primer co-autor el dr. Félix Guerrrero Ramos, urólogo del Hospital Universitario 12 de Octubre pubmed.ncbi.nlm.nih.gov/33012593/

This month in actasurologicas we publish a review that shows an important association between HPV and #bladder cancer. The association between the human papillomavirus (HPV) and the diagnos... sciencedirect.com/science/articl…

🔴Check out our recent participation at UroToday.com “Beyond the Abstract” 👩🏻‍🏫Insights from the first author Cgdelcanizo from Department of Urology, Hospital 12 De Octubre about the value of preop cytology in Urologic Oncology 🤓Read it here: t.ly/V0Uvx GUO-AEU bibliotecah12o Mario Hernández Arroyo UroSoMe RAEU - Spanish Urology Residents Working Group

🚨 Exciting Update! 🚨 Our new EVITA (EV Ineligible criTeriA) criteria for identifying patients ineligible for the EV/Pembro combo in #metastaticurothelialcarcinoma has just been published in European Urology!!!! This breakthrough could significantly reshape daily clinical practice!

Enrique Grande European Urology Galsky criteria, Gupta criteria… all G, why not Grande criteria? 😂 🔝 Enrique Grande as usual!!! Huge congrats to all for this novel concept!!!!

🆒Clin Obs GU cancer program! Proud to coordinate with Daniel Castellano 2 weeks ago 📖Both theoretical and practical 🎤Highly interactive, 25 physicians from all over the world at our Hospital 😃Great success! 📻Stay tuned for more national & international editions 🔴Thanks MSD España

🎯🎯 a great GU multidisciplinary program including Lab training (Elena Castro David Olmos) a Nuclear Medicine course (#adolfogomez SEMNIM) and simulation practice based pts (Félix Guerrero-Ramos). Thanks a global @MSD support!

🚨Check-out our paper just released in the Special Issue from Cancers MDPI “Targeted Therapy for Bladder Cancer” ✍🏼We wrote about immune predictors of response to #BCG in #NMIBC Marta Dueñas Cgdelcanizo Mario Hernández Arroyo Department of Urology, Hospital 12 De Octubre ROC Clinic 🔗Read it: t.ly/GwV1x

Dr. Guerrero-Ramos on the evolving treatment landscape in NMIBC urologytimes.com/view/dr-guerre… vía @urologytimes Shahrokh F. Shariat Antoni Vilaseca Ashish M. Kamat, MD, MBBS Sia Daneshmand, M.D. Morgan Roupret Paolo Gontero European Urology Oncology UroSoMe GUO-AEU European Association of Urology (EAU) Óscar Rodríguez Faba Mario AlvarezMaestro bibliotecah12o GUARD Consortium

Available the last Newsletter by Devicare reviewing the communications about #UTIs presented during the Spanish Association of Urology Meeting 2024 c0k21.r.sp1-brevo.net/mk/mr/sh/SMJz0…

📽️UroToday.com Beyond the Abstract 👓Take a look at the video-summary of our recently published paper at European Urology Oncology European Association of Urology (EAU) 🚨No need to read to be updated, as easy as watching 🤪 📺Watch it here: t.ly/yNA1- UroSoMe EAU Edu Platform UROONCO GUO-AEU GUARD Consortium bibliotecah12o

Video in @UroToday: @Urodocash interviews Félix Guerrero-Ramos novel treatments for non-muscle-invasive bladder cancer (NMIBC). Click here to watch the video: urotoday.com/video-lectures…

🔝Different format: a pleasure to be interviewed by Ashish M. Kamat, MD, MBBS and share insights with him on #NMIBC 📽️Hot of the press by UroToday.com 📺Watch it here: t.ly/0p5g3 Department of Urology, Hospital 12 De Octubre bibliotecah12o UroSoMe GUO-AEU European Urology Oncology EAU Edu Platform UROONCO GUARD Consortium IBCG

🎤Interview at Urology Times 🔀Risk stratification is essential in #NMIBC 💉Proper risk assessment leads to proper treatment 🤓Read it: t.ly/q12xV 📰Published in Bladder Cancer 👥Jose Daniel Subiela Óscar Rodríguez Faba Julia Aumatell Celeste Manfredi Javier Romero Otero Felipe Couñago PhD

UroToday.com : Great talk about new delivery systems in NMIBC. Félix Guerrero-Ramos Ashish M. Kamat, MD, MBBS Sia Daneshmand, M.D. Stephen Boorjian, MD urotoday.com/video-lectures…

Isabel Lorenzo Raul Calvo Rico Isabel Lorenzo nuestra Sociedad Científica AEU no se ha inventado nada. Por otro lado, estas revisiones, con PSA y tacto rectal, pueden llevarse a cabo en Medicina Familiar y Comunitaria. Creo que te equivocas con lo de “llenar nuestras consultas privadas”. Un saludo.

🚨About BCGu NMIBC: “In selected patients, initial BST offers comparable survival to RC. Rates of rec and prog increase over time, especially in patients treated with additional lines of BST” 📉BUT: comparable CSS 🔗 t.ly/sHk4G BJU International Ashish M. Kamat, MD, MBBS Roger Li